CABALETTA BIO, INC. (CABA): Price and Financial Metrics
CABA Price/Volume Stats
| Current price | $3.71 | 52-week high | $26.35 |
| Prev. close | $3.55 | 52-week low | $3.47 |
| Day low | $3.49 | Volume | 1,105,000 |
| Day high | $3.80 | Avg. volume | 1,089,002 |
| 50-day MA | $4.48 | Dividend yield | N/A |
| 200-day MA | $11.44 | Market Cap | 181.23M |
CABA Stock Price Chart Interactive Chart >
CABALETTA BIO, INC. (CABA) Company Bio
Cabaletta Bio, Inc. operates as a clinical-stage biotechnology company, which engages in the discovery and development of engineered T cell therapies for B cell-mediated autoimmune diseases. Its proprietary technology utilizes chimeric autoantibody receptor to selectively bind and eliminate B cells that produce disease-causing autoantibodies. The company was founded by Michael C. Milone, Steven Nichtberger, and Aimee Payne in 2017 and is headquartered in Philadelphia, PA.
CABA Price Returns
| 1-mo | N/A |
| 3-mo | N/A |
| 6-mo | N/A |
| 1-year | N/A |
| 3-year | N/A |
| 5-year | N/A |
| YTD | N/A |
| 2023 | N/A |
| 2022 | N/A |
| 2021 | N/A |
| 2020 | N/A |
| 2019 | N/A |
Loading social stream, please wait...